Annual report & consolidated financial statements 2025
Page 3
14. SHARE CAPITAL
Issued allotted & Paid share capital
|
|
2025 |
2024 |
|
|
Number |
Number |
|
Ordinary shares |
|
|
|
Ordinary shares of 0.1p in issue |
653,102,371 |
275,852,371 |
|
Subdivision of shares from 0.1p to 0.01p |
(653,102,371) |
|
|
After subdivision of share to 0.01p |
653,102,371 |
|
|
Issued ordinary shares of 0.01p in year |
226,250,000 |
377,250,000 |
|
Total ordinary shares of 0.1p in issue |
879,352,371 |
653,102,371 |
|
Deferred shares |
|
|
|
Deferred shares of 0.9p in issue |
287,144,228 |
287144228 |
|
Subdivision of shares at 0.09p |
653,102,371 |
0 |
|
Consolidation of shares from 0.09p |
(653,102,371) |
|
|
After consolidation of shares to 0.9p |
65,310,238 |
|
|
Total Deferred shares of 0.9p in issue |
352,454,466 |
287,144,228 |
Background and current year position -
Ordinary Shares:
On 18 August 2023, the company issued 125,000,000 new ordinary shares at 0.1p as a result of placing of shares that raised gross proceeds of £125,000. The funds raised provide the Company with additional working capital.
On 27 March 2024, 26,000,000 ordinary shares at 0.1p per ordinary share were issued in order to settle certain liabilities amounting to £26,000.
On 27 March 2024, a convertible loan note with an aggregate amount of £905,000 was fully converted into 226,250,000 ordinary shares at 0.4p per ordinary shares. Previously, in year 2022, the Company agreed with C C Johnson a consolidation and variation of terms of the two unsecured convertible loan notes and direct debt held by him. As a result of the consolidation and variation agreement, the total amount owed to C. C Johnson was converted into an unsecured convertible loan note with an aggregate amount of £905,000, which was set to expire on 31 July 2024 but was fully converted into equity during the year. Further to the conversion, C C Johnson has instructed the Company's Broker, Peterhouse Capital Limited ("Peterhouse") to immediately place the entirety of the 2022 Conversion Shares, at a price of £0.00044 per share (a 12% discount to the mid-
On 7 November 2024, C C Johnson issued a conversion notice to the Company in relation to the entirety of the £99,550 unsecured convertible loan notes held by him in the Company (the "2024 CLN"). As a result, and as per the original terms of the 2024 CLN, the Company has issued to C C Johnson 226,250,000 new Ordinary Shares at £0.00044 per ordinary share,
Deferred Shares:
On 13 July 2020 the Company undertook a sub-
On 04 November 2024, the company undertook a sub-
Deferred shares do not entitle the holder to receive notice of and to attend or vote at any general meeting of the Company or to receive dividends or other distributions. Upon winding up or dissolution of the Company the holders of deferred shares shall be entitled to receive an amount equal to the nominal amount paid up thereon, but only after holders of ordinary shares have received £100,000 per ordinary share. Holders of deferred shares are not entitled to any further rights of participation in the assets of the Company. The Company has the right to purchase the deferred shares in issue at any time for no consideration.
|
|
2025 |
2024 |
|
|
£ |
£ |
|
On demand or within one year |
966,250 |
0 |
|
In the second year |
18,287 |
0 |
|
In the third to fifth years inclusive |
- |
- |
|
After five years |
0 |
476,410 |
|
|
984,537 |
476,410 |
|
Amount due for settlement within 12 months (included in current liabilities) |
966,250 |
0 |
|
Amount due for settlement after 12 months |
18,287 |
476,410 |
The weighted average interest rates paid on the bank loans were as follows:
Bank loans: 11.04% (2024: 3.4%)
All of the Directors’ loans are repayable after more than 1 year . All loans are interest bearing and charged accordingly. However, C C Johnson has waived his right to interest in the current year and the previous year. Interest was paid to Mr J Dubois at the rate of nil pa (2024: 12% pa).
Historic loan notes with a nominal value of £600,000 and £200,000 respectively were rolled up into a new convertible loan note agreement in the year 2022 along with related party loans of £105,000 to create a new convertible loan note with a nominal value of £905,000. The liability in respect of this transaction was disclosed within directors loans above with a present value as at 31st March 2024 of £nil due to the conversion of the loan notes during the period. As a financial instrument with both debt and equity components, an amount had been recognised directly into a Loan Note Equity Reserve on issue, with the debt element being unwound at an implied interest rate of 10% and the interest recognized through profit and loss.
The remaining directors loan balance is disclosed in note 15.
Included in other loans is £100,000 (2024: £560,000) advanced by G Howard (son-
In addition, included in other loans is as loan agreement entered into by the Group on 3 June 2024 with Ecap Esports Ltd ("Ecap Esports"). Ecap Esports had agreed to loan the Company the sum of £250,000 to cover any abortive costs associated with a proposed reverse takeover, which never materialised. The loan bears no interest. The current amount owed to Ecap Esports as at year end is £23,965.
The bank borrowings are repayable as follows:
|
|
2025 |
2024 |
|
|
£ |
£ |
|
Directors' loans |
2,924,789 |
2,219,819 |
|
Other loans |
283,465 |
719,500 |
|
Bank loans - |
984,537 |
476,410 |
|
|
4,192,791 |
3,415,729 |
|
Being |
|
|
|
Less than one year |
966,250 |
|
|
More than one year |
3,226,541 |
3,415,729 |
|
|
4,192,791 |
3,415,729 |
11. INVENTORY
|
|
2025 |
2024 |
|
|
£ |
£ |
|
Work in progress |
1,310,069 |
775,374 |
Inventories recognised as an expense during the period totalled £nil (2024: £nil). Borrowing costs capitalized in the year total £40,581 (2024: £38,208 ).
Write-
Inventories pledged as security for liabilities as at year end totaled £765,000 (2024: £275,000 ).
A 10% fall in the estimated future value of the property would result in an impairment totaling £59,500 (2024: £80,000).
A 10% fall in the estimated future value of the property would result in an impairment totalling £80,000.
12. TRADE AND OTHER PAYABLES
|
|
2025 |
2024 |
|
|
£ |
£ |
|
Trade payables |
235,034 |
152,745 |
|
Taxation & social security |
15,513 |
12,130 |
|
Accruals |
97,552 |
120,739 |
|
|
348,099 |
285,614 |
13. BORROWINGS